Thymic stromal lymphopoietin (TSLP) is a cytokine that binds the IL-7-receptor-a chain and a unique TSLP receptor (TSLPR) chain. The role of TSLP in human B-cell development has not been elucidated. We show that TSLPR transcripts are expressed most prominently in CD341 cells from fetal liver and BM. In general, cell surface expression of TSLPR was low, except on a subset of multilineage-commited progenitor cells. TSLP induced the tyrosine-phosphorylation of STAT5 and the proliferation of multilineage-commited progenitor cells, pro-B cells and pre-B cells. Compared with IL-7, the levels of proliferation after stimulation of the B-cell progenitors with TSLP were lower. Expression of the BCR on the cell surface of fetal cells was inversely correlated to TSLP or IL-7 responsiveness. Pre-B cells from fetal BM, but not fetal liver, were refractory to TSLP or IL-7 stimulation. When employing an in vitro B-cell differentiation culture system starting from CD34 1 CD38À multipotent HSC, IL-7 induced a short wave of precursor cell expansion but did not result in long-term survival of mature B cells. TSLP was capable of increasing the proportion and the absolute numbers of more mature human B cells. Overall, we provide evidence that TSLP supports human B-cell differentiation from fetal hematopoietic progenitors.Key words: Fetal . Human B-cell development . IL-7 . Thymic stromal lymphopoietin Supporting Information available online
IntroductionHuman immunodeficiencies have uncovered the key role of cytokine signaling pathways in lymphocyte development.Patients suffering from X-linked SCID (X-SCID), which is caused by a loss of function mutation in the common g (Cg) chain, or patients with defective IL-7-receptor-a (IL-7Ra) chain expression, are accompanied by severely diminished T-lymphopoiesis but apparently normal B-cell numbers [1,2]. This has raised the suggestion that in humans, B-cell development is IL-7 independent. In contrast, in mice, IL-7 is a major cytokine involved in B-cell development, since both IL-7-deficient and IL-7Ra-deficient mice showed a profound block at an early stage of B-cell development, i.e. at the pro-B cell to pre-B cell transition [1,[3][4][5]. Interestingly, fetal and early postnatal B-lymphopoiesis in the mouse have been described to be largely driven by IL-7-independent mechanisms [3,5,6]. It has been proposed that thymic stromal lymphopoietin (TSLP) acts as a primary regulator of IL-7-independent fetal B-lymphopoiesis [7,8]. This, together with the fact that B-cell development in SCID patients has been analyzed only in infants, questions the importance of TSLP during fetal human B-cell genesis. TSLP and IL-7 have overlapping biological activities, although they are not homologous [9]. Both IL-7 and TSLP signal via a [10,11]. A common downstream event of both IL-7 and TSLP-induced signaling is the tyrosine phosphorylation of the transcription factor STAT5 [13], which then translocates to the nucleus where it initiates transcription of target genes. Most cytokine receptors, including the re...